Connection

Thilo Jakob to Urticaria

Back to Details
This is a "connection" page, showing publications Thilo Jakob has written about Urticaria.
Thilo Jakob
Connection Strength
0.400
Urticaria
  1. Omalizumab treatment in patients with chronic inducible urticaria: A systematic review of published evidence. J Allergy Clin Immunol. 2018 02; 141(2):638-649.
    View in: PubMed
    Score: 0.108
  2. Omalizumab is effective in symptomatic dermographism-results of a randomized placebo-controlled trial. J Allergy Clin Immunol. 2017 09; 140(3):870-873.e5.
    View in: PubMed
    Score: 0.106
  3. H1-antihistamine-refractory chronic spontaneous urticaria: it's worse than we thought - first results of the multicenter real-life AWARE study. Clin Exp Allergy. 2017 May; 47(5):684-692.
    View in: PubMed
    Score: 0.105
  4. Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy. J Allergy Clin Immunol. 2013 Jul; 132(1):101-9.
    View in: PubMed
    Score: 0.081
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.